cyclin d1 (Proteintech)

Proteintech is a verified supplier

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Proteintech cyclin d1
Cyclin D1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1621 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d1/Cyclin+D1+Antibody/pm42837419-87-9-16
Average 96 stars, based on 1621 article reviews

cyclin d1 - by Bioz Stars, 2026-10

96/100 stars

Images

Staining:

Article Title: A multimodal ROS logic-gated therapeutic platform disrupts the vicious cycle of senescence to promote aged bone defect repair
Article Snippet: .. Tissue sections were stained for γ-H2A.X (Servicebio, GB111841 , 1:500), p62 (Affinity, AF5384, 1:500), p16 (Santa Cruz, sc-81156, 1:200), p21 (Affinity, AF6290, 1:300), Cyclin D1 (Proteintech, 26939-1-AP, 1:200), MMP-2 (Servicebio, GB11130, 1:500), IL-6 (Servicebio, GB11117, 1:200), and TNF-α (Servicebio, GB115702 , 1:200) following standard protocols. .. Fluorescent images were acquired using a panoramic digital slide scanner (VS200, Olympus, Japan).

Knock-Out:

Article Title: CGP60474, a novel MITD1-targeted inhibitor for bladder cancer progression via CDK4/cyclin D1 pathway modulation
Article Snippet: .. Antibodies against MITD1 (17264-1-AP, Proteintech), Tubulin (66240-1-Ig, Proteintech), β-Actin (66009-1-Ig, Proteintech), CDK4 (11026-1-AP, 66950-1-Ig, Proteintech), cyclin D1 (26939-1-AP, 60186-1-Ig, Proteintech), DYKDDDDK tag Monoclonal Fig. 7 | Genetic knockout ofMITD1 via CRISPR-Cas9 impairs proliferation and induces cell cycle arrest in UMUC-3 cells. ..

CRISPR:

Incubation:

Article Title: Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer
Article Snippet: Equal amounts of protein (30 μg) were separated by 10% SDS-PAGE and transferred onto PVDF membranes (Millipore, United States). .. Membranes were blocked with 5% non-fat milk in TBST and incubated overnight at 4 °C with primary antibodies against SPHK1 (1:1000; Abcam, ab71700), Bax (1:1000; Cell Signaling Technology, #2772), CDC2 (1:1000; Abcam, ab18), Cyclin D1 (1:2000; Proteintech, 26939-1-AP), p21 (1:1000; Cell Signaling Technology, #2947), p27 (1:1000; Cell Signaling Technology, #3686), TGF-β1 (1:500; R&D Systems, AF-246-NA), N-cadherin (1:5000; Sigma-Aldrich, C3865), E-cadherin (1:5000; Sigma-Aldrich, MAB3199), and α-tubulin (1:5000; Sigma-Aldrich, T6199). .. After washing, the membranes were incubated with HRP-conjugated secondary antibodies (1:5000; Cell Signaling Technology) for 1 h at room temperature.

Article Title: A comprehensive analysis of common cytogenetic abnormalities in multiple myeloma: from basic research to clinical applications.
Article Snippet: The significant heterogeneity of multiple myeloma (MM) profoundly impacts patient prognosis, with cytogenetic abnormalities serving as a core driver.. Based on the International Myeloma Working Group and 2024 International Myeloma Society consensus, this study enrolled 52 newly diagnosed MM patients.. Six cytogenetic abnormalities—RB1 deletion, D13S319 deletion, immunoglobulin heavy chain (IGH) translocation, 1q21 gain/ amplification, P53 deletion, and 1p32 deletion—were detected using fluorescence in situ hybridisation.

Cell-Signaling:

other:

Article Title: Zhuche Pill alleviates DSS-induced colonic epithelial injury in mice: involvement of IL-17/NF-κB and Wnt/β-catenin signaling pathways.
Article Snippet: Ethnopharmacological relevance: Zhuche Pill (ZCP), a traditional Chinese medicine formula first documented in Qianjin Yaofang during the Tang Dynasty, has been used for centuries to treat dysentery-associated gastrointestinal disorders, including abdominal pain, diarrhea, hematochezia, and tenesmus.. Despite the long-standing clinical application of ZCP, the pharmacological basis underlying its therapeutic effects remains incompletely understood.. Aim of the study: This study aims to evaluate the protective effects of ZCP against colitis and explore its potential underlying mechanisms.

Review